HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chisholm, J. W. Articles by Dolphin, P. J. Search for Related Content PubMed PubMed Citation Articles by Chisholm, J. W. Articles by Dolphin, P. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1086-1098, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis

JW Chisholm and PJ Dolphin
Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia, Canada.

The alpha-naphthylisothiocyanate (ANIT)-treated rat was evaluated as a model for lipoprotein metabolism in cholestatic liver disease. Alterations in lipoprotein composition over a period of 120 h after ANIT treatment (100 mg/kg) were studied. Eighteen hours after treatment, plasma bilirubin and bile acid levels began to rise, together with significant increases in free cholesterol. C-18/16, C- 18/18, and C-18/20 phospholipid molecular species. By 48 h, plasma lipid levels were maximal, free cholesterol was 935%, cholesteryl ester 294%, phospholipid 611%, and triacylglycerols 176% of controls, and the cholesteryl ester to free cholesterol ratio began to recover with a modest shift from cholesteryl esters containing C-20 fatty acids to those containing C-18 fatty acids. Lecithin: cholesterol acyltransferase activity was near normal, lipoprotein lipase activity was increased, and hepatic triacylglycerol lipase activity was decreased. Density gradient ultracentrifugation of rat plasma demonstrated a marked shift in lipoprotein density towards the low density lipoprotein range, with the increased lipid being associated with apolipoproteins A-I and E. The presence of large 300-400 A particles and the high surface to core lipid ratio in this density range was consistent with the presence of lipoprotein-X-like vesicles. Apolipoprotein B-48 accumulation was observed in the high density fractions (d15 > 1.063 g/ml) suggesting that these rats have impaired lipoprotein remnant removal. All of these increased levels returned to near normal by 120 h. This study demonstrates that ANIT-treatment induces a transient, fully reversible, non-surgical intrahepatic cholestasis that results in many of the plasma lipoprotein abnormalities associated with human hepatic cholestasis and the bile duct-ligated rat.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. E. Amacher, R. Adler, A. Herath, and R. R. Townsend Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy Clin. Chem., October 1, 2005; 51(10): 1796 - 1803. [Abstract] [Full Text] [PDF]

				J. W. Chisholm, J. Hong, S. A. Mills, and R. M. Lawn The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse J. Lipid Res., November 1, 2003; 44(11): 2039 - 2048. [Abstract] [Full Text] [PDF]

				J. W. Chisholm, A. K. Gebre, and J. S. Parks Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1999; 40(8): 1512 - 1519. [Abstract] [Full Text]

				J. W. Chisholm, P. Nation, P. J. Dolphin, and L. B. Agellon High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1165 - G1173. [Abstract] [Full Text] [PDF]